Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management

Jennifer Vaz; Alexandra Mulliken; Nivin Omar; Jessa Suhner; Bogna Brzezinska; Thomas Cotter; Patel Nikhil; Robert V Higgins; Bunja Rungruang

doi:10.1016/j.gore.2022.101068

Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management

Gynecol Oncol Rep. 2022 Sep 17:43:101068. doi: 10.1016/j.gore.2022.101068. eCollection 2022 Oct.

Authors

Jennifer Vaz¹, Alexandra Mulliken¹, Nivin Omar², Jessa Suhner¹, Bogna Brzezinska¹, Thomas Cotter², Patel Nikhil², Robert V Higgins¹, Bunja Rungruang¹

Affiliations

¹ Division of Gynecologic Oncology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
² Pathology Department, Medical College of Georgia at Augusta University, Augusta, GA, United States.

Abstract

Background: A pure ovarian dysgerminoma in a postmenopausal female is a rare phenomenon.

Case: A 65-year-old female presented with a large pelvic mass. Following surgical debulking, the patient was diagnosed with FIGO Stage IIB ovarian dysgerminoma. She was treated with three cycles of etoposide and cisplatin and has been disease-free for 12 months.

Conclusion: Dysgerminomas in postmenopausal females are uncommon. Gynecologic oncologists should be familiar with the pathological diagnosis and treatment recommendations to achieve optimal outcomes.

Keywords: Germ cell tumor; Ovarian germ cell tumor; Pure ovarian dysgerminoma.

Publication types

Case Reports